(91 days)
Unknown
The document mentions "clinical advisories including EWS deterioration status" and "Early Warning Scoring capability". While Early Warning Scoring systems can be implemented using simple rule-based logic, they can also incorporate more complex algorithms, potentially including ML. Without further detail on the implementation of the EWS, it's impossible to definitively say if AI/ML is used. The document does not explicitly mention AI, ML, or related terms.
No
The document explicitly states that the IntelliVue CL SpO2 Pod and the IntelliVue CL NBP Pod are not therapeutic devices. The IntelliVue Guardian Software is a Clinical Information Management System and not a therapeutic device.
Yes
The IntelliVue CL SpO2 Pod and IntelliVue CL NBP Pod acquire and monitor physiological patient parameters (SpO2, pulse rate, NBP), and the IntelliVue Guardian Software collects, stores, and manages this data, as well as providing clinical advisories including EWS deterioration status, which are all used for diagnostic purposes by healthcare providers.
No
While the IntelliVue Guardian Software component is described as "software only," the submission also includes modifications to the IntelliVue CL SpO2 Pod and IntelliVue CL NBP Pod, which are explicitly described as hardware devices (wrist-worn pulse oximeter and noninvasive blood pressure device). The 510(k) covers the system as a whole, which includes both software and hardware components.
Based on the provided information, none of the described devices are IVDs (In Vitro Diagnostics).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Device Functions:
- IntelliVue Guardian Software: This software collects, stores, and manages physiological data from patient monitors and cableless measurement devices. It provides features like trending, reporting, alarming, and clinical documentation. It does not analyze specimens from the body.
- IntelliVue CL SpO2 Pod: This device measures arterial oxygen saturation and pulse rate using a sensor placed on the patient's body. It does not analyze specimens from the body.
- IntelliVue CL NBP Pod: This device measures non-invasive blood pressure and pulse rate using a cuff placed on the patient's body. It does not analyze specimens from the body.
All of these devices are designed to measure physiological parameters directly from the patient's body, not to analyze specimens taken from the body. Therefore, they fall under the category of medical devices but not In Vitro Diagnostic devices.
N/A
Intended Use / Indications for Use
-
IntelliVue Guardian Software:
The IntelliVue Guardian Software is indicated for use by healthcare providers whenever there is a need for generation of a patient record.
The IntelliVue Guardian Software is intended for use in the collection, storage and management of data from IntelliVue Cableless Measurements and IntelliVue Patient Monitors that are connected through networks. -
IntelliVue CL SpO2 Pod:
The IntelliVue CL SpO2 Pod is indicated for use by health care professionals whenever there is a need for acquisition or monitoring of physiological patient parameters Sp02 and pulse rate wirelessly.
The intended use of the IntelliVue CL SpO2 Pod when used together with a patient monitor or with a telemetry system transceiver is for monitoring, recording, and alarming of arterial oxygen saturation and pulse rate of adult and pediatric patients.
The IntelliVue CL SpO2 Pod is also intended for acquisition of arterial oxygen saturation and pulse rate data of adult and pediatric patients for a clinical information management system.
The IntelliVue CL SpO2 Pod is intended for use by health care professionals inside hospitals. It is not intended for home use. It is not a therapeutic device. -
IntelliVue CL NBP Pod:
The IntelliVue CL NBP Pod is indicated for use by health care professionals whenever there is a need for acquisition or monitoring of physiological patient parameters non-invasive blood pressure and pulse rate wirelessly.
The intended use of the IntelliVue CL NBP Pod when used together with a patient monitor or with a telemetry system transceiver is for monitoring, recording, and alarming of systolic, diastolic, and mean pressure and pulse rate of adult and pediatric patients.
The IntelliVue CL NBP Pod is also intended for acquisition of systolic, diastolic, and mean pressure and pulse rate data of adult and pediatric patients for a clinical information management system.
The IntelliVue CL NBP Pod is intended for use by health care professionals inside hospitals. It is not intended for home use. It is not a therapeutic device.
Product codes
DXJ, MSX, DSI, DSK, DSJ, DXQ, DXN, DXG, DRT, DRQ, DQA, DRG, DSA
Device Description
-
New IntelliVue Guardian Software: The new IntelliVue Guardian Software is a Clinical Information Management System. It collects and manages vital signs data acquired from the IntelliVue Cableless Measurements and IntelliVue patient monitors. The Guardian Software provides trending, review, reporting, notification, clinical documentation, calculations, clinical advisories including EWS deterioration status, remote viewing and operating, interfacing, storage, and printing. The IntelliVue Guardian Software is software only product intended to be installed on a customer supplied PC or Server.
-
Modified IntelliVue CL SpO2 Pod: The IntelliVue CL SpO2 Pod is a small, battery powered, wrist worn pulse oximeter device. It contains Philips FAST-Sp02 (Fourier Artifact Suppression Technology) to provide reliable saturation values under various artifact conditions including motion and low perfusion. It provides continuous operating mode and intermittent operating mode with configurable measuring intervals. Integrated monochrome LCD display shows measured values, measurement signal quality, battery state, and RF signal strength. It has three hardkeys for basic operation and navigation. It supports specialized Philips reusable and disposable SpO2 sensors. The modification is solely limited to the labeling change in order to indicate the usage of this device together with the new Philips IntelliVue Guardian Software.
-
Modified IntelliVue CL NBP Pod: The IntelliVue CL NBP Pod is a small, battery powered, noninvasive blood pressure and pulse rate measurement device. It uses oscillometric method for measuring NBP. It produces numerics for systolic, diastolic and mean blood pressure values and pulse rate. Integrated monochrome LCD Display shows measured values, battery state, and RF signal strength. It has three hardkeys for basic operation and navigation. It supports specialized Philips reusable and disposable NBP cuffs. The modification is limited to the labeling change in order to indicate the usage of this device together with the new Philips IntelliVue Guardian Software.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult and pediatric patients
Intended User / Care Setting
healthcare providers, health care professionals inside hospitals. It is not intended for home use.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
- Non-Clinical Performance Tests (bench testing): The purpose of the performance testing was to ensure the performance of the new IntelliVue Guardian Software by verifying and stressing the PC server and client specifications and simulating various scenarios of real customer deployments in the hospital. The conducted performance tests have confirmed static and dynamic performance of the complete system comprising the new IntelliVue Guardian Software installed on server and clients, the compatible measuring devices, and the hospital IT infrastructure according to the specifications, under conditions simulating real environment of use.
- Clinical Evaluation: The objective of the Clinical Evaluation was to ensure that the new IntelliVue Guardian Software, used together with the compatible IntelliVue Patient Monitors MP5/MP5SC and IntelliVue Cableless Measurements CL SpO2 Pod/NBP Pod was clinically useful and would be accepted by the clinical users. The performed Clinical Evaluation has shown that the new IntelliVue Guardian Software, with its Early Warning Scoring capability, in combination with the compatible measuring devices was clinical useful and was accepted by the clinical users.
- Further Testing: Testing as identified in the Hazard Analysis, Functionality resting on the new IntelliVue Guardian Software, Functionality Testing on the IntelliVue CL SpO2 Pod together with the new IntelliVue Guardian Software, Functionality Testing on the IntelliVue CL NBP Pod together with the new IntelliVue Guardian Software, Functionality Testing on the IntelliVue CL SpO2/CL NBP Pod and Philips proprietary access point CL Hotspot with the new IntelliVue Guardian Software, Remote Operating Functionality Testing on the IntelliVue CL SpO2/CL NBP Pod and the new IntelliVue Guardian, Remote Viewing Functionality Testing on the IntelliVue CL SpO2/CL NBP Pod and the new IntelliVue Guardian Software, Functionality testing on the IntelliVue Patient Monitor MP5/MP5SC together with the new IntelliVue Guardian Software.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
K082633, K083517, K091927, K093268, K100939, K101449, K102562, K110622, K101600
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2450 Medical cathode-ray tube display.
(a)
Identification. A medical cathode-ray tube display is a device designed primarily to display selected biological signals. This device often incorporates special display features unique to a specific biological signal.(b)
Classification. Class II (performance standards).
0
510 (k) Summary
OCT - 4 2011
This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of the Safe Medical Devices Act of 1990 and 21 C.F.R. §807.92.
-
- The submitter of this Premarket Notification is: Markus Stacha Philips Medizin Systeme Boeblingen GmbH Hewlett-Packard-Str. 2 D-71034 Boeblingen, Germany Tel: ++49 7031 463-2840, Fax: ++49 7031 463-2442 e-mail: markus.stacha@philips.com
This summary was prepared on June 30, 2011.
- The submitter of this Premarket Notification is: Markus Stacha Philips Medizin Systeme Boeblingen GmbH Hewlett-Packard-Str. 2 D-71034 Boeblingen, Germany Tel: ++49 7031 463-2840, Fax: ++49 7031 463-2442 e-mail: markus.stacha@philips.com
-
- The name of the device:
- New device: Trade name: IntelliVue Guardian Software, Revision A.00 Common name: Clinical Information Management System
- Modified devices (labeling modification only) : Trade name: IntelliVue CL SpO2 Pod Common name: Telemetry Transceiver
Trade name: IntelliVue CL NBP Pod Common name: Telemetry Transceiver
Classification names of the new IntelliVue Guardian Software are as follows:
| Device Panel | Classification | ProCode | Description |
|---|---|---|---|
| General | |||
| Hospital | not classified | NSX | Software, transmission and |
| storage, patient data | |||
| Cardiovascular | |||
| Devices | §870.2450, II | DXJ | Display, cathode-ray tube, |
| medical |
Classification names of the modified (labeling modification only) IntelliVue CL Sp02 Pod and CL NBP Fod are as follows:
| Device Panel | Classification | ProCode | Description |
|---|---|---|---|
| Cardiovascular | |||
| Devices | $870.1025, II | DSI | Detector and Alarm, Arrhythmia |
| $870.1100, II | DSJ | Alarm, Blood-Pressure | |
| $870.1110, II | DSK | Computer, Blood-Pressure | |
| $870.1120, II | DXQ | Cuff, Blood-Pressure | |
| $870.1130, II | DXN | System, Measurement, Blood- | |
| Pressure, Non-Invasive | |||
| $870.1435, II | DXG | Computer, Diagnostic, Pre- | |
| Programmed, Single-Function | |||
| $870.2030, II | DRT | Monitor, Cardiac (incl. | |
| Cardiotachometer & Rate Alarm) | |||
| $870.2060, II | DRQ | Amplifier and Signal | |
| Conditioner, Transducer Signal |
1
Image /page/1/Picture/0 description: The image shows the word "PHILIPS" in a bold, sans-serif font. The letters are filled with a textured pattern, giving them a slightly distressed or vintage appearance. The overall impression is of a clear and legible representation of the brand name.
| Device Panel | Classification | ProCode | Description |
|---|---|---|---|
| $870.2700, II | DQA | Oximeter | |
| $870.2900, I | DSA | Cable, Transducer and | |
| Electrode, incl. Patient | |||
| Connector | |||
| $870.2910, II | DRG | Transmitters and Receivers, | |
| Physiological Signal, | |||
| Radiofrequency | |||
| - | MSX | System, Network and | |
| Communication, Physiological | |||
| Monitors |
- The new Philips IntelliVue Guardian Software, Rev. A.00, is substantially equivalent to the previously cleared Philips IntelliVue Clinical Information Portfolio marketed pursuant to K992636 and K100272, Philips IntelliVue XDS application software K082633, K083517, K091927, K093268, K100939, K101449, K102562, K110622, and Philips IntelliVue Early Warning Scoring application K093268, K102562, K110622.
The modified Philips IntelliVue CL SpO2 Pod and CL NBP Pod are substantially equivalent to the previously cleared IntelliVue CL SpO2 Pod and CL NBP Pod marketed pursuant to K101600.
4. Description of the device
New IntelliVue Guardian Software;
The new IntelliVue Guardian Software is a Clinical Information Management System. It collects and manages vital signs data acquired from the IntelliVue Cableless Measurements and IntelliVue patient monitors. The Guardian Software provides trending, review, reporting, notification, clinical documentation, calculations, clinical advisories including EWS deterioration status, remote viewing and operating, interfacing, storage, and printing.
The IntelliVue Guardian Software is software only product intended to be installed on a customer supplied PC or Server. The IntelliVue Guardian Software is compatible with the following measuring devices:
- Philips IntelliVue Cableless Measurements CL SpO2 Pod and -CL NBP Pod,
- Philips IntelliVue MP5 and MP5SC patient monitors. l
Modified IntelliVue CL SpO2 Pod:
The IntelliVue CL SpO2 Pod is a small, battery powered, wrist worn pulse oximeter device. It contains Philips FAST-Sp02 (Fourier Artifact Suppression Technology) to provide reliable saturation values under various artifact conditions including motion and low perfusion. It provides continuous cperating mode and intermittent operating mode with configurable measuring me intervals. Integrated monochrome LCD display shows measured values, measurement signal quality, battery state, and RF signal strength. It has three hardkeys for basic operation and
2
navigation. It supports specialized Philips reusable and disposable SpO2 sensors.
The IntelliVue CL Sp02 Pod remains unchanged as it is. The modification, which is subject of this Premarket Notification, is solely limited to the labeling change in order to indicate the usage of this device together with the new Philips IntelliVue Guardian Software.
Modified IntelliVue CL NBP Pod:
The IntelliVue CL NBP Pod is a small, battery powered, noninvasive blood pressure and pulse rate measurement device. It uses oscillometric method for measuring NBP. It produces numerics for systolic, diastolic and mean blood pressure values and pulse rate. Integrated monochrome LCD Display shows measured values, battery state, and RF signal strength. It has three hardkeys for basic operation and navigation. It supports specialized Philips reusable and disposable NBP cuffs.
The IntelliVue CL NBP Pod remains unchanged as it is. The modification, which is subject of this Premarket Notification, is limited to the labeling change in order to indicate the usage of this device together with the new Philips IntelliVue Guardian Software.
The IntelliVue CL SpO2 Pod and CL NBP Pod are compatible with the following medical devices:
- Philips IntelliVue Patient Monitors MP5, MP5T, MP5SC, MP2, X2 .
- Philips IntelliVue Telemetry System Transceiver TRx4841A and . TRx4851A
- . Philips IntelliVue Guardian Software
5. Intended Use/ Indications for Use
New IntelliVue Guardian Software:
The new IntelliVue Guardian Software is indicated for use by healthcare providers whenever there is a need for generation of a patient record.
The IntelliVue Guardian Software is intended for use in the collection, storage and management of data from IntelliVue Cableless Measurements and IntelliVue Patient Monitors that are connected through networks.
The indication statements of the subject device IntelliVue Guardian Software are the same as those of the predicate Philips Intellivia Clinical Information Portfolio Software, except that the subject device provides a subset of the indications of the predicate device. Whereas the predicate is indicated for generation of a patient record and for computation of drug dosage, the subject device is only indicated for generation of a patient record. Whereas the predicate is intended for use with ary Philips or third-party vendor medical measuring devices, the subject device is only intended for use with a limited number of Philips Intellive medical measuring devices. For this reason the different indication statements do not impact the safety and effectiveness of the subject device.
3
Modified IntelliVue CL SpO2 Pod:
The IntelliVue CL SpO2 Pod is indicated for use by health care professionals whenever there is a need for acquisition or monitoring of physiological patient parameters Sp02 and pulse rate wirelessly.
The intended use of the IntelliVue CL SpO2 Pod when used together with a patient monitor or with a telemetry system transceiver is for monitoring, recording, and alarming of arterial oxygen saturation and pulse rate of adult and pediatric patients.
The IntelliVue CL SpO2 Pod is also intended for acquisition of arterial oxygen saturation and pulse rate data of adult and pediatric patients for a clinical information management system.
The IntelliVue CL SpO2 Pod is intended for use by health care professionals inside hospitals. It is not intended for home use. It is not a therapeutic device.
Modified IntelliVue CL NBP Pod:
The IntelliVue CL NBP Pod is indicated for use by health care professionals whenever there is a need for acquisition or monitoring of physiological patient parameters non-invasive blood pressure and pulse rate wirelessly.
The intended use of the IntelliVue CL NBP Pod when used together with a patient monitor or with a telemetry system transceiver is for monitoring, recording, and alarming of systolic, diastolic, and mean pressure and pulse rate of adult and pediatric patients.
The IntelliVue CL NBP Pod is also intended for acquisition of systolic, diastolic, and mean pressure and pulse rate data of adult and pediatric patients for a clinical information management system.
The IntelliVue CL NBP Pod is intended for use by health care professionals inside hospitals. It is not intended for home use. It is not a therapeutic device.
The above indication statements of the IntelliVue CL SpO2 Pod/ CL NBP Pod have been modified in order to emphasize that the acquired physiological data can not only be used for monitoring purposes but also for a clinical information management system.
The indication statements have also been modified to reduce the level of specificity with regard to the compatible medical devices. Whereas the previous indication statements have contained detailed references to the particular models of the compatible medical devices, the modified indication statements reference the type of compatible devices. The detailed information on compatible medical devices is still contained in the device labeling, such as Instructions for Use. Therefore, this indication statement modification does not affect the safety and effectiveness of the IntelliVue CL Spo2 Pod/ CL NBP Pod.
4
Image /page/4/Picture/0 description: The image shows the word "PHILIPS" in a bold, sans-serif font. The letters are large and take up most of the frame. The text has a textured appearance, with a grainy or speckled pattern filling each letter.
The intended use of the IntelliVue CL SpO2 Pod/ CL NBP Pod has not changed. The same clinical users can measure the same physiological parameters of the same target patient population in the same environment of use. The use of acquired physiological data for an information management system does not affect the safety and effectiveness of the IntelliVue CL SpO2 Pod/ CL NBP Pod. This use is considerably less critical, compared to the previously cleared use of measurement data acquired from these devices for monitoring and alarming purposes.
6. Technological Characteristics
New IntelliVue Guardian Software: The new Philips IntelliVue Guardian Software, Rev. A.00, has the same technological characteristics as the legally marketed predicate Philips IntelliVue Clinical Information Portfolio software. The Guardian Software is software only product intended to be
installed on a standard PC or Server. It has client server architecture and it is compliant with the up to date Microsoft® Operating System and databases.
The Guardian Software supports a standard hospital LAN interface and Philips device interfaces for connection to the compatible measuring devices.
Modified IntelliVue CL SpO2 Pod and CL NBP Pod:
The modification to the IntelliVue CL SpO2 Pod/ CL NBP Pod is solely limited to the labeling change in order to indicate the usage of these devices together with the new Philips IntelliVue Guardian Software. This labeling modification does not affect the technological characteristics of the IntelliVue CL Sp02 Pod/ CL NBP Pod.
7.Summary of performed testing
Non-Clinical Performance Tests (bench testing) : The purpose of the performance testing was to ensure the performance of the new IntelliVue Guardian Software by verifying and stressing the PC server and client specifications and simulating various scenarios of real customer deployments in the hospital.
The conducted performance tests have confirmed static and dynamic performance of the complete system comprising the new Intellivum Guardian Software installed on server and clients, the compatible measuring devices, and the hospital IT infrastructure according to the specifications, under conditions simulating real environment of use.
Clinical Evaluation:
The objective of the Clinical Evaluation was to ensure that the new IntelliVue Guardian Software, used together with the compatible IntelliVue Patient Monitors MP5/MP5SC and Intellivue
5
Image /page/5/Picture/0 description: The image displays the word "PHILIPS" in a bold, sans-serif font. The letters are textured with a pattern that gives them a slightly rough or distressed appearance. The overall impression is of a clear and recognizable brand name.
Cableless Measurements CL SpO2 Pod/NBP Pod was clinically useful and would be accepted by the clinical users.
The performed Clinical Evaluation has shown that the new IntelliVue Guardian Software, with its Early Warning Scoring capability, in combination with the compatible measuring devices was clinical useful and was accepted by the clinical users.
Further Testing:
- Testing as identified in the Hazard Analysis,
- Functionality resting on the new IntelliVue Guardian Software,
- Functionality Testing on the IntelliVue CL SpO2 Pod together with the new IntelliVue Guardian Software
- ו Functionality Testing on the IntelliVue CL NBP Pod together with the new IntelliVue Guardian Software
- Functionality Testing on the IntelliVue CL SpO2/CL NBP Pod and 1 Philips proprietary access point CL Hotspot with the new IntelliVue Guardian Software
- Remote Operating Functionality Testing on the IntelliVue CL ، SpO2/CL NBP Pod and the new IntelliVue Guardian
- Remote Viewing Functionality Testing on the IntelliVue CL ı Spo2/CL NBP Pod and the new IntelliVue Guardian Software
- Functionality testing on the IntelliVue Patient Monitor MP5/ ı MP5SC together with the new IntelliVue Guardian Software.
The results of this testing have confirmed safe, effective, and reliable function within specifications of the new IntelliVue Guardian Software used together with compatible IntelliVue patient monitors MP5/MP5SC and IntelliVue Cableless Measurements CL Sp02 Pod/CL NBP Pod, in the specified IT infrastructure.
8. Conclusion
Verification and validation testing activities were conducted to establish the performance, safety, effectiveness, functionality, usability, and reliability characteristics of the new and modified devices.
V&V testing included bench performance tests, functionality tests, system tests, and clinical evaluation. All tests were successfully completed.
The results demonstrate that the new IntelliVue Guardian Software and the modified IntelliVue CL SpO2 Pod, CL NBP Pod are as safe, as effective and perform as well as the predicate devices. The new and modified devices are substantially equivalent in intenced use and fundamental technological characteristic In
appropriate prodicate decided in appropriate predicate devices. The devices introduce no new questions concerning the safety or efficacy and are, therefore, substantially equivalent to the predicate devices.
6
Image /page/6/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. In the center of the circle is a stylized symbol that resembles an eagle or a bird in flight, composed of three curved lines.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Philips Medizin Systeme Boeblingen GmbH c/o Mr. Markus Stacha Hewlett-Packard-Str. 2 D-71034 Boeblingen Germany
4 2011
Re: K111905
Trade/Device Name: IntelliVue Guardian Software, Revision A.00.01 and IntelliVue CL SpO2 Pod and CL NBP Pod Regulation Number: 21 CFR 870.2450 Regulation Name: Medical Cathode-Ray Tube Display Regulatory Class: Class II (two) Product Codes: DXJ, MSX, DSI, DSK, DSJ, DXQ, DXN, DXG, DRT, DRQ, DQA, DRG, DSA Dated: September 22, 2011 Received: September 26, 2011
Dear Mr. Stacha:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
7
Page 2 – Mr. Markus Stacha
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
8
Indications for Use
510(k) Number (if known): K111905
$p^{1/2}$
Device Name:
- Philips IntelliVue Guardian Software, Revision A.00 -
- Philips IntelliVue CL SpO2 Pod and CL NBP Pod ।
Indications for Use:
IntelliVue Guardian Software:
The IntelliVue Guardian Software is indicated for use by healthcare providers whenever there is a need for generation of a patient record.
The IntelliVue Guardian Software is intended for use in the collection, storage and management of data from IntelliVue Cableless Measurements and IntelliVue Patient Monitors that are connected through networks.
continued on next page
| Prescription (Part 21 CFR 801 Subpart D) | Use | Yes | AND/OR | Over-The-Counter (21 CFR 807 Subpart C) | Use | No |
|---|---|---|---|---|---|---|
| ------------------------------------------ | ----- | ----- | -------- | ----------------------------------------- | ----- | ---- |
(PLEASE DO NOT WRITE BELOW THIS LINE- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Cardiovascular Devices
| 510(k) Number | K111905 |
|---|---|
| --------------- | --------- |
9
Indications for Use (continued) :
KII1905 p2/2
IntelliVue CL SpO2 Pod:
The IntelliVue CL SpO2 Pod is indicated for use by health care professionals whenever there is a need for acquisition or monitoring of physiological patient parameters Sp02 and pulse rate wirelessly.
The intended use of the IntelliVue CL SpO2 Pod when used together with a patient monitor or with a telemetry system transceiver is for monitoring, recording, and alarming of arterial oxygen saturation and pulse rate of adult and pediatric patients.
The IntelliVue CL SpO2 Pod is also intended for acquisition of arterial oxyger saturation and pulse rate data of adult and pediatric patients for a clinical information management system.
The IntelliVue CL SpO2 Pod is intended for use by health care professionals inside hospitals. It is not intended for home use. It is not a therapeutic device.
IntelliVue CL NBP Pod:
The IntelliVue CL NBP Pod is indicated for use by health care professionals whenever there is a need for acquisition or monitoring of physiological patient parameters non-invasive blood pressure and pulse rate wirelessly.
The intended use of the IntelliVue CL NBP Pod when used together with a patient monitor or with a telemetry system transceiver is for monitoring, recording, and alarming of systolic, diastvlir, and mean pressure and pulse rate of adult and pediatric, patients.
The IntelliVue CL NBP Pod is also intended for acquisition of systolic, diastolic, and mean pressure and pulse rate data of adult and pediatric patients for a clinical information management system.
The IntelliVue CL NBP Pod is intended for use by health care professionals inside hospitals. It is not intended for home use. It is not a therapeutic device.